Generic medicine

Budesonide + Formoterol Fumarate: Brands, Price & Uses in Bangladesh

Budesonide + Formoterol Fumarate is a fixed-dose combination inhaler containing an inhaled corticosteroid (budesonide) and a long-acting beta2-agonist (formoterol fumarate) and more.

Forms:Dry Powder Inhalation Capsule (DPI)InhalerMultidose Dry Powder Inhaler (MDPI)

About Budesonide + Formoterol Fumarate

Indications of Budesonide + Formoterol Fumarate

Budesonide + Formoterol Fumarate is a fixed-dose combination inhaler containing an inhaled corticosteroid (budesonide) and a long-acting beta2-agonist (formoterol fumarate), indicated for the following:

Established / Approved Uses

  • Maintenance treatment of asthma in patients (typically 6 years of age and older, depending on the specific product strength and local labeling) who require regular treatment with both an inhaled corticosteroid and a long-acting bronchodilator, including patients whose asthma is not adequately controlled on an inhaled corticosteroid alone.
  • Maintenance treatment of airflow obstruction in chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema, and to reduce the frequency of COPD exacerbations in adult patients.

Guideline-Supported Additional Use

  • In some countries, under specific asthma treatment guidelines (e.g., GINA), certain strengths of Budesonide + Formoterol Fumarate are used as combined maintenance-and-reliever therapy in adults; this specific reliever role is not part of every national label and should only be followed under a physician's explicit instruction.

Not Indicated For

  • Budesonide + Formoterol Fumarate is not a rescue/quick-relief inhaler for acute bronchospasm or a first-line treatment for status asthmaticus or other acute episodes of asthma/COPD requiring intensive intervention (see Contraindications).

Dosage & Administration of Budesonide + Formoterol Fumarate

General Principles

Budesonide + Formoterol Fumarate is administered by oral inhalation only, on a regular scheduled basis (not as needed). The lowest strength that effectively controls symptoms should be used, and the dose should be individualized by the treating physician.

IndicationTypical Adult DosingNotes
Asthma maintenance (adults and adolescents)Usually 2 inhalations twice daily (morning and evening) of the strength prescribedSome regimens allow once-daily dosing in mild disease; follow physician's instructions
COPD maintenanceUsually 2 inhalations twice daily of the higher-strength productNot for once-daily use in COPD; twice-daily regular dosing
Pediatric asthma (where approved, generally 6 years and older)2 inhalations twice daily of the lowest appropriate pediatric strengthUse only the strength/device approved for the child's age; see Pediatric Use

Administration Technique

  • Shake the inhaler (for pressurized metered-dose inhalers) before use, as directed in the product leaflet.
  • Exhale fully before inhaling, then inhale slowly and deeply while actuating the device, and hold the breath for about 10 seconds.
  • Rinse the mouth with water and spit it out after each use to reduce the risk of oral thrush (candidiasis) and hoarseness.
  • Do not use extra doses or double the dose to relieve sudden breathing problems; a separate fast-acting rescue inhaler should be available for acute symptoms.

Side Effects of Budesonide + Formoterol Fumarate

Side effects of Budesonide + Formoterol Fumarate may involve either the inhaled corticosteroid component, the long-acting beta2-agonist component, or both.

Common Side Effects

  • Oral candidiasis (thrush) and throat irritation
  • Hoarseness or voice changes (dysphonia)
  • Headache
  • Nasopharyngitis, upper respiratory tract infection, sinusitis
  • Nausea
  • Back pain, muscle cramps
  • Tremor and palpitations (related to the beta-agonist component)

Less Common but Serious Side Effects

  • Paradoxical bronchospasm (worsening of wheeze immediately after use) — discontinue and seek medical advice if this occurs
  • Increased risk of pneumonia in COPD patients
  • Cardiovascular effects: increased heart rate, palpitations, arrhythmias, and rarely QT prolongation
  • Hypokalemia (low blood potassium) and hyperglycemia
  • Adrenal suppression and Cushingoid features with long-term, high-dose use (see Precautions)
  • Reduced bone mineral density with long-term use
  • Slowing of growth velocity in children (see Pediatric Use)
  • Vision changes, glaucoma, or cataracts with long-term use
  • Hypersensitivity reactions, including rash, urticaria, angioedema, and rarely anaphylaxis

Contraindications of Budesonide + Formoterol Fumarate

Budesonide + Formoterol Fumarate is contraindicated in the following situations:

  • Known hypersensitivity to budesonide, formoterol fumarate, or any excipient of the specific formulation.
  • As a primary treatment for acute bronchospasm, status asthmaticus, or other acute episodes of asthma or COPD requiring intensive measures; Budesonide + Formoterol Fumarate is not a rescue inhaler and does not act rapidly enough to treat acute symptoms.

Frequently Asked Questions about Budesonide + Formoterol Fumarate

What is Budesonide + Formoterol Fumarate used for?

Budesonide + Formoterol Fumarate is a combination inhaler used for the long-term, regular maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD). It is not a rescue inhaler for sudden breathing problems.

Can I use Budesonide + Formoterol Fumarate when I am having a sudden asthma attack?

No. Budesonide + Formoterol Fumarate is not intended to relieve acute bronchospasm or asthma attacks; it acts as regular maintenance therapy. Patients should keep a separate fast-acting rescue inhaler on hand for sudden symptoms, and seek urgent medical care if a severe attack occurs.

Why do I need to rinse my mouth after using Budesonide + Formoterol Fumarate?

Budesonide + Formoterol Fumarate contains an inhaled corticosteroid, which can occasionally cause oral thrush (a fungal infection of the mouth/throat) or hoarseness. Rinsing the mouth with water and spitting it out after each use significantly reduces this risk.

Is Budesonide + Formoterol Fumarate safe during pregnancy or breastfeeding?

Budesonide + Formoterol Fumarate should be used during pregnancy or while breastfeeding only if a physician determines that the benefit clearly outweighs any potential risk, since uncontrolled asthma itself can be harmful to both mother and baby. Always consult your physician before starting, stopping, or continuing Budesonide + Formoterol Fumarate during pregnancy or lactation.

What are the most serious risks associated with Budesonide + Formoterol Fumarate?

Budesonide + Formoterol Fumarate contains a long-acting beta2-agonist (LABA), a class of medicines that carries a boxed warning for increased risk of asthma-related death when used alone without an inhaled corticosteroid; because Budesonide + Formoterol Fumarate always combines the LABA with an inhaled corticosteroid, this specific risk is reduced when the medicine is used exactly as prescribed. Other risks include cardiovascular effects, adrenal suppression, and reduced bone density with long-term use — discuss any concerns with your physician.

Can children use Budesonide + Formoterol Fumarate?

Budesonide + Formoterol Fumarate is approved for asthma maintenance in children from a specific age depending on the product strength (commonly 6 years and older); it should only be given to a child on a physician's prescription, using the strength and device approved for that child's age, with regular monitoring of growth.

Disclaimer

The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.

DoctorBlogArticles